A detailed history of Blue Capital, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Blue Capital, Inc. holds 24,751 shares of BSX stock, worth $2.54 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares
24,751
Previous 21,494 15.15%
Holding current value
$2.54 Million
Previous $2.31 Billion 4.67%
% of portfolio
1.79%
Previous 1.64%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$97.03 - $108.14 $316,026 - $352,211
3,257 Added 15.15%
24,751 $2.42 Billion
Q2 2025

Aug 14, 2025

BUY
$89.7 - $107.41 $1.08 Million - $1.3 Million
12,075 Added 128.2%
21,494 $2.31 Billion
Q4 2024

Feb 14, 2025

BUY
$83.62 - $91.5 $787,616 - $861,838
9,419 New
9,419 $841 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Blue Capital, Inc. Portfolio

Follow Blue Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blue Capital, Inc. with notifications on news.